PI3K/AKT/mTOR pathway plays a pivotal role in cancer pathogenesis and progression, and mTOR is frequently activated in various malignancies, such as breast, prostate, lung, liver, and kidney cancers (Posadas, Limvorasak & Figlin, 2017). Here, AKT1 is linked to kidney cancer.